Fundraising FoxBios Partners — Full Portfolio
19 tracked investments · listed companies and verified rows first
Actuate Therapeutics is a clinical-stage biopharmaceutical company developing elraglusib, a small-molecule GSK-3β inhibitor designed to treat difficult-to-treat cancers including pancreatic, melanoma, lung, and pediatric cancers through intravenous injection and oral tablet formulations.
BiotechFort Worth, US
Daniel Schmitt(President & Chief Executive Officer)Paul Lytle(Executive Officer)inAndrew Mazar(Executive Officer)
BoardTodd Thomson(Director)inRoger Sawhney(Director)Jason Keyes(Director)
Board seatAaron G.L. FletcherAaron G.L. FletcherLeslie W. Kreis, Jr.· per SEC Form D
Co-investorsIllinois VenturesKairos Venture Investments, LlcBiosDEFTA PartnersTech Coast Angels
Azitra is a clinical-stage biopharmaceutical company developing genetically engineered bacteria and proteins for treating skin diseases through precision dermatology.
AI & Machine LearningBiotechHealthtechFarmington, US
Francisco D. Salva(President and Chief Executive Officer)inAzim Munivar(Executive Officer, Director, Promoter)
Board seatStella RobertsonTravis Whitfill· per SEC Form D
Co-investorsConnecticut InnovationsKdT VenturesLeaps by Bayer
Cue Biopharma is a precision immunotherapy company developing engineered therapies targeting allergic and autoimmune diseases.
BiotechHealthtechMedical DevicesBoston, US
Daniel Baker(Executive Officer)Colin Sandercock(Executive Officer)inDominic Borie(Chief Medical Officer and Head of Research and Development)inSumita Ray(Executive Officer)inMichael Meluzio(Executive Officer)inRodolfo Chaparro(Vice President, Head of Immunology)in
Board seatAaron G.L. Fletcher· per SEC Form D · $30M raise · filed Nov 2022
IN8bio is a clinical-stage biopharmaceutical company developing gamma-delta T cell therapies for solid and hematological tumors using its DeltEx platform (allogeneic, autologous, iPSC, and genetically modified approaches).
BiotechHealthtechNew York, US
Lawrence Lamb(Scientific Founder & Chief Scientific Officer)inWilliam Ho(Founder & Chief Executive Officer)inKate Rochlin(Executive Officer)inPatrick McCall(Executive Officer)inTravis Whitfill(Director)inMelissa Beelen(Executive Officer)
Board seatTravis Whitfill· per SEC Form D · $35M raise · filed Sep 2020
EquipmentShare provides construction equipment rentals and fleet management technology for builders and contractors.
Construction TechIoTPropTechSaaSColumbia, US
Brad Siegler(Founder)inJeff Lowe(Founder)inJabbok Schlacks(Founder)inWilliam Schlacks(Founder)inWilly Schlacks(Founder)
BoardNeil Chheda(Director)
Co-investorsY CombinatorAmity VenturesDepth VenturesEvolution VC PartnersFundersClubG Squared+28 more
Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.
BiotechHealthtechMedical DevicesSan Diego, US
David Eveleth(Executive Officer, Director)inSchalon Newton(Executive Officer)in
BoardChristy Shaffer(Director)inRalph Bradshaw(Director)
Board seatStella Robertson· per SEC Form D
Co-investorsExSight VenturesHatteras Venture PartnersSolasta VenturesAccess BiotechnologyCorrelation VenturesFemHealth Ventures+1 more
ONL Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve sight by preventing Fas-mediated death of retinal cells, a cause of vision loss and blindness.
BiotechHealthtechMedical DevicesAnn Arbor, US
David Zacks(Co-Founder & Chief Scientific Officer)inDavid Esposito(Executive Officer, Director)inConstance Chang(Executive Officer)John K Freshley(Executive Officer, Director)inJeffrey A Jamison(Executive Officer)in
BoardAaron Fletcher(Director)in
Co-investorsExSight VenturesInvest MichiganNovartis Venture FundVisionary VenturesInFocus Capital Partners, LLCJohnson & Johnson Innovation – JJDC+3 more
410 Medical makes LifeFlow, a hand-operated rapid infuser that lets clinicians quickly deliver blood or fluids to critically ill patients needing volume resuscitation.
HardwareHealthtechMedical DevicesDurham, US
Mark Donald Piehl(Executive Officer, Director)KYLE CHENET(Executive Officer, Director)in
BoardJEFF TERRELL(Director)inSTANLEY D. LYNALL(Director)FRED GOLDWATER(Director)inMAYANK TANEJA(Director)in
Board seatTravis Whitfill· per SEC Form D · $4M raise · filed Aug 2018
Co-investorsBallad VenturesCU Healthcare Innovation FundDuke Capital PartnersOSF VenturesWellstarWolfpack Investor Network+2 more
BiotechAustin, US
James Brian Windsor(President and CEO)Steven Idell(Director)
BoardAaron Fletcher(Director)inJoseph Woelkers(Director)Robert Mills(Director)
Board seatAaron G.L. Fletcher· per SEC Form D
Co-investorsUT Horizon Fund
Actuate provides AI-based video analytics that turn existing IP cameras and NVRs into a security detection system, offering real-time alerts for threats such as intruders, loitering, guns, and crowds.
AI & Machine LearningCloud ComputingCybersecurityGovTechSaaS
Sonny Tai(Co-Founder)inKen Francis(CEO)in
Co-investorsBling CapitalDorm RoomGray Line PartnersMetaPropMetaProp VenturesScribble Ventures+4 more
Bluesmart manufactures connected luggage with integrated app controls for travelers seeking location tracking and mobile device management features.
ConsumerHardwareNew York City, US
Alejo Verlini(Founder)in
Co-investorsCota CapitalFundersClubGerman VenturesMind the Seed - MTS FundY CombinatorACE & Company+18 more
Call9 provides emergency and palliative care to patients in skilled nursing facilities by combining onsite clinical care specialists with remote emergency medicine physicians who evaluate and treat patients via a proprietary platform, reducing response times from an average of 64 minutes to immediate care.
HealthtechNew York City, US
Celina Tenev(Founder)
Co-investorsFundersClubY CombinatorGreat Oaks Venture CapitalHillcrest Venture PartnersIndex VenturesJoe Lonsdale+8 more
Convox provides a platform for deploying and managing cloud-native applications across multiple cloud providers including AWS, Google Cloud, and Azure.
Cloud ComputingData & InfrastructureDeveloper ToolsEnterprise SoftwareAtlanta, US
David Dollar(Founder)inNoah Zoschke(Founder)inMatt Manning(Founder)in
Co-investorsCurious CapitalGarage CapitalHeavybitY CombinatorInovia CapitalProsperity7 Ventures+4 more
.jpeg)
Encore Vision supplies eyewear frames and operates a full-service digital optical lab, offering combined frame-and-lens solutions to eyecare practices.
HealthtechRetail TechFort Worth, US
Evelyn Blake(Executive Officer)William R. Burns(Executive Officer, Director)in
BoardLes Kreis(Director)Robert Willard(Director)John Hunkeler(Director)Adrienne Graves(Director)
Co-investorsCowtown Angels
Pomello provides organizational culture assessment software that evaluates team dynamics and integrates with recruitment workflows to identify job candidates likely to succeed within a company's specific culture.
AI & Machine LearningEnterprise SoftwareHR TechSaaSSan Francisco, US
Oliver Staehelin(Founder)inCatherine Spence(Founder)in
Co-investorsSoma CapitalY CombinatorChina Growth CapitalHaystackNew Enterprise Associates (NEA)PreAngel Fund
Stream Biomedical is a clinical-stage biotechnology company developing LG3, a biologic derived from a natural repair protein intended to protect and restore the brain by activating its repair systems.
BiotechDeep TechHealthtechHouston, US
H. Davis Adkisson(Chief Scientific Officer)inChris Garabedian(Director)William Schwieterman(Board of Directors)Fred Callori(Director)
BoardAmanda De La Garza(Director)in
Co-investorsCowtown Angels
Yhat provided a platform for managing the complete lifecycle of data science projects, from model development through deployment.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareNew York City, US
Austin Ogilvie(Founder)inGreg Lamp(Founder)in
Co-investorsboldstart venturesContour Venture PartnersLongley CapitalRRE VenturesY CombinatorCollaborative Fund+4 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
BobcatBioSIRPant Immunotherapeutics, Inc.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.